에 대한 최신 뉴스 Mannatech (NASDAQ:MTEX) 주식

Mannatech

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

Mannatech Inc

General

MTEX

CORRECTION: Mannatech reported Q1 financial results on May 13.

Mannatech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEX#NASDAQ">MTEX</a>) reported quarterly losses of $(0.80) per share. This is a 226.98 percent decrease over earnings of $0.63 per share from the same period last year. The company reported $26.56 million in sales this quarter. This is a 9.63 percent decrease over sales of $29.39 million the same period last year.

Earnings

News

Mannatech Q1 EPS $(0.80) Down From $0.63 YoY, Sales $26.56M Down From $29.39M YoY

Mannatech Q4 EPS $1.20 Up From $(0.94) YoY, Sales $29.01M Down From $32.69M YoY

Mannatech Q3 EPS $(0.17) Down From $0.01 YoY, Sales $31.7M Down From $32.6M YoY

The Notice has no immediate effect on the listing or trading of the Company&rsquo;s common stock on The Nasdaq Global Market and the common stock will continue to trade under the symbol &ldquo;MTEX&rdquo;.
If the plan is accepted, Nasdaq can grant an extension of up to 180 calendar days from the date of the Notice, or until February 15, 2025, to evidence compliance. If the plan is not accepted, the Company will have the right to appeal and the common stock would remain listed on The Nasdaq Global Market until the completion of the appeal process. To regain compliance, the Company must have stockholders&rsquo; equity of at least $10 million.

Mannatech Says It Received Written Notification From Nasdaq Listing Qualifications Department About Non-Compliance Of Listing Rule

Mannatech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEX#NASDAQ">MTEX</a>) reported quarterly losses of $(0.33) per share. This is a 44.07 percent increase over losses of $(0.59) per share from the same period last year. The company reported $27.70 million in sales this quarter. This is a 15.02 percent decrease over sales of $32.59 million the same period last year.

Mannatech Q2 EPS $(0.33) Up From $(0.59) YoY, Sales $27.70M Down From $32.59M YoY

Management

Mannatech Appoints James Clavijo As CFO, Effective July 1, 2024

Mannatech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEX#NASDAQ">MTEX</a>) reported quarterly earnings of $0.63 per share. This is a 96.88 percent increase over earnings of $0.32 per share from the same period last year. The company reported $29.39 million in sales this quarter. This is a 13.84 percent decrease over sales of $34.11 million the same period last year.

Mannatech Q1 EPS $0.63 Up From $0.32 YoY, Sales $29.39M Down From $34.11M YoY

Mannatech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEX#NASDAQ">MTEX</a>) reported quarterly losses of $(0.94) per share. This is a 75.13 percent increase over losses of $(3.78) per share from the same period last year. The company reported $32.69 million in sales this quarter. This is a 4.78 percent decrease over sales of $34.34 million the same period last year.

Mannatech Q4 EPS $(0.94) Up From $(3.78) YoY, Sales $32.69M Down From $34.34M YoY

Mannatech, Incorporated&nbsp;(NASDAQ:&nbsp;<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fmtex%3Fltr%3D1&amp;esheet=53910093&amp;newsitemid=20240313782516&amp;lan=en-US&amp;anchor=MTEX&amp;index=2&amp;md5=505740f2f7d7393216dd3d0fb05a053a">MTEX</a>) reported that Alfredo (Al) Bala, announced his retirement as the company&#39;s CEO effective April 1, 2024. J. Stanley Fredrick, Chairman of the Board of Mannatech.
Mr. Fredrick further stated, &quot;Coinciding with Al&#39;s retirement, I am pleased to announce the promotion of Landen Fredrick to the position of President and CEO. Landen&#39;s succession to the CEO position was made possible by Al&#39;s mentorship over the past few years where Landen served as President and Chief Operating Officer. As CEO, Landen will oversee the senior executive team and the team of general managers over our international markets, driving operational excellence, and executing the company&#39;s strategic initiatives.&quot;

Mannatech Announces Promotion Of Landen Fredrick To President And CEO

Mannatech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEX#NASDAQ">MTEX</a>) reported quarterly losses of $(0.59) per share. This is a 273.53 percent decrease over earnings of $0.34 per share from the same period last year. The company reported $32.60 million in sales this quarter. This is a 6.79 percent decrease over sales of $34.98 million the same period last year.

Mannatech Q2 EPS $(0.59) Down From $0.34 YoY, Sales $32.60M Down From $34.98M YoY

Mannatech Announces New Tiered Affiliate Program Pre-Launch

Mannatech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEX#NASDAQ">MTEX</a>) reported quarterly earnings of $0.32 per share. This is a 433.33 percent increase over earnings of $0.06 per share from the same period last year. The company reported $34.11 million in sales this quarter. This is a 5.34 percent increase over sales of $32.38 million the same period last year.

Mannatech Q1 EPS $0.32 Up From $0.06 YoY, Sales $34.11M Up From $32.38M YoY

Mannatech Announces Formation Of New Wholly Owned Subsidiary That Will Serve As Its Innovation Hub

<h3>Gainers</h3>
<ul>
<li>Barnes &amp; Noble Education, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bned#NYSE">BNED</a>) jumped 39% to $2.39 after the company posted better-than-expected quarterly sales.</li>
<li>Molecular Templates, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtem#NASDAQ">MTEM</a>) rose 29.7% to $0.61. Molecular Templates received FDA clearance to proceed for clinical testing of its novel MT-8421 ETB program.</li>
<li>Jeffs&#39; Brands Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jfbr#NASDAQ">JFBR</a>) gained 23% to $1.7110. Jeffs&#39; Brands recently entered into a definitive agreement to acquire the entire share capital of Fort Products Ltd for $1.92 million.</li>
<li>PLAYSTUDIOS, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/myps#NASDAQ">MYPS</a>) gained 20.5% to $4.1814 after reporting upbeat quarterly results.</li>
<li>Unicycive Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uncy#NASDAQ">UNCY</a>) shares rose 19.7% to $2.47 after jumping 27% on Thursday. The company recently announced a private placement of up to $130 million in gross proceeds to commercialize and launch Renazorb.</li>
<li>PlayAGS, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ags#NYSE">AGS</a>) shares gained 18.3% to $7.51 after the company posted better-than-expected Q4 results.</li>
<li>Mannatech, Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtex#NASDAQ">MTEX</a>) rose 18.2% to $21.00.</li>
<li>Heritage Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hgbl#NASDAQ">HGBL</a>) shares climbed 16.6% to $2.8799 after the company reported strong Q4 financial results.</li>
<li>View, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/view#NASDAQ">VIEW</a>) rose 16% to $0.6596. View is expected to report Q4 financial results after the market close on March 29, 2023.</li>
<li>Riskified Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rskd#NYSE">RSKD</a>) gained 14.7% to $6.17. Piper Sandler upgraded Riskified from Neutral to Overweight and raised the price target from $6 to $8.</li>
<li>MamaMancini&#39;s Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mmmb#NASDAQ">MMMB</a>) gained 13.6% to $1.60.</li>
<li>Intuitive Machines, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lunr#NASDAQ">LUNR</a>) rose 12.4% to $18.21 after gaining around 58% on Thursday.</li>
<li>Bird Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brds#NASDAQ">BRDS</a>) gained 11.3% to $0.2003 after the company reported better-than-expected Q4 sales results.</li>
<li>Theriva Biologics, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tovx#NYSE">TOVX</a>) jumped 11% to $0.82.</li>
<li>Silvergate Capital Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/si#NYSE">SI</a>) shares rose 8.6% to $3.0850. Silvergate Capital shares dipped 42% on Thursday after the company announced it will wind down operations and voluntarily liquidate Silvergate Bank.</li>
<li>Bon Natural Life Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bon#NASDAQ">BON</a>) gained 8.5% to $1.53.</li>
<li>XIAO-I Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aixi#NASDAQ">AIXI</a>) rose 6.4% to $6.18. Xiao-I reported pricing of initial public offering.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Loyalty Ventures Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lylt#NASDAQ">LYLT</a>) fell 47.6% to $0.3020 after the company announced bankruptcy filings and plans to delist from the Nasdaq Global Select Market.</li>
<li>GlucoTrack, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gctk#NASDAQ">GCTK</a>) dropped 33.3% to $0.3999.</li>
<li>First Republic Bank (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/frc#NYSE">FRC</a>) shares dipped 31.2% to $66.06. The stock is sharply lower as shares of several regional banks and financial institutions sell off on downward momentum after SVB Financial Group Wednesday announced a $1.25 billion common stock offering.</li>
<li>Allbirds, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bird#NASDAQ">BIRD</a>) fell 30.9% to $1.6301 after the company announced weaker-than-expected Q4 results. Allbirds also named Annie Mitchell as Chief Financial Officer.</li>
<li>Alto Ingredients, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alto#NASDAQ">ALTO</a>) dropped 27.2% to $2.0599 after the company reported worse-than-expected Q4 EPS and sales results.</li>
<li>Fresh Tracks Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/frtx#NASDAQ">FRTX</a>) fell 26.6% to $0.9175. Fast Track Therapeutics recently announced, in its Phase 1 study, FRTX-02 was generally safe and well tolerated within the potential therapeutic dose range, meeting the study&#39;s primary objectives.</li>
<li>a.k.a. Brands Holding Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aka#NYSE">AKA</a>) dropped 24.8% to $1.00. a.k.a. Brands Holding reported weaker-than-expected financial results for the fourth quarter.</li>
<li>PacWest Bancorp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pacw#NASDAQ">PACW</a>) fell 23.9% to $15.14 in sympathy with SVB Financial Group after the company announced a $1.25 billion common stock offering.</li>
<li>Western Alliance Bancorporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wal#NYSE">WAL</a>) fell 22.7% to $48.21.</li>
<li>BYND Cannasoft Enterprises Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcan#NASDAQ">BCAN</a>) dropped 22.5% to $3.20.</li>
<li>Alta Equipment Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/altg#NYSE">ALTG</a>) fell 21.1% to $15.20 following Q4 results.</li>
<li>Genius Sports Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/geni#NYSE">GENI</a>) fell 21% to $4.09. Genius Sports reported fourth-quarter FY22 sales growth of 25.4% year-on-year to $105.34 million, beating the consensus of $104.35 million.</li>
<li>Century Casinos, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnty#NASDAQ">CNTY</a>) dropped 19.4% to $6.78 following weak quarterly results.</li>
<li>DocuSign, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/docu#NASDAQ">DOCU</a>) shares fell 18% to $52.83 after the company reported fourth-quarter results and announced its CFO will step down.</li>
<li>Greenbrook TMS Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbnh#NASDAQ">GBNH</a>) dropped 18% to $0.8118.</li>
<li>AirSculpt Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/airs#NASDAQ">AIRS</a>) fell 17.8% to $4.6350 following weak sales.</li>
<li>Quanex Building Products Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nx#NYSE">NX</a>) dipped 17% to $20.57 following weak earnings.</li>
<li>Oncternal Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/onct#NASDAQ">ONCT</a>) dropped 16.9% to $0.7362 following weak sales.</li>
<li>Motorsport Games Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/msgm#NASDAQ">MSGM</a>) declined 15.4% to $10.21.</li>
<li>TG Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tgtx#NASDAQ">TGTX</a>) dropped 14.6% to $14.29. TG Therapeutics recently announced the schedule of data presentations highlighting data from its ULTIMATE I and II Phase 3 trials evaluating BRIUMVI.</li>
<li>JinkoSolar Holding Co., Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jks#NYSE">JKS</a>) fell 14.4% to $48.06 after the company reported mixed Q4 financial results.</li>
<li>Nuvve Holding Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvve#NASDAQ">NVVE</a>) declined 14.1% to $0.6289.</li>
<li>Signature Bank (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbny#NASDAQ">SBNY</a>) fell 13.7% to $78.35.</li>
<li>CareMax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmax#NASDAQ">CMAX</a>) fell 13.7% to $3.3827.</li>
<li>Poseida Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pstx#NASDAQ">PSTX</a>) dropped 13.5% to $4.37. HC Wainwright &amp; Co. reiterated Poseida Therapeutics with a Buy and maintained a $15 price target.</li>
<li>Airgain, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/airg#NASDAQ">AIRG</a>) fell 13.5% to $5.97 after the company reported worse-than-expected Q4 EPS and sales results.</li>
<li>JAKKS Pacific, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jakk#NASDAQ">JAKK</a>) dropped 13.1% to $16.00 after the company reported worse-than-expected Q4 EPS results.</li>
<li>Novo Integrated Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvos#NASDAQ">NVOS</a>) shares fell 12.4% to $0.1388 after dropping 18% on Thursday.</li>
<li>B. Riley Financial, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rily#NASDAQ">RILY</a>) dropped 12.3% to $31.96.</li>
<li>Diversified Healthcare Trust (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dhc#NYSE">DHC</a>) fell 12.2% to $1.5450.</li>
<li>Ocean Biomedical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocea#NASDAQ">OCEA</a>) shares dropped 11.5% to $9.31. Ocean Biomedical shares jumped 125% on Thursday after the company&#39;s co-founder presented details of his previously published discoveries that have potential application for tumor suppression across multiple cancer pathways.</li>
<li>Comtech Telecommunications Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmtl#NASDAQ">CMTL</a>) declined 11% to $13.75.</li>
<li>Opendoor Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/open#NASDAQ">OPEN</a>) fell 9.5% to $1.22.</li>
<li>Metropolitan Bank Holding Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mcb#NASDAQ">MCB</a>) dropped 9% to $45.87.</li>
<li>Scholar Rock Holding Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srrk#NASDAQ">SRRK</a>) fell 8.3% to $9.04.</li>
<li>Q2 Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qtwo#NASDAQ">QTWO</a>) dipped 8.1% to $27.34.</li>
<li>Asana, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/asan#NYSE">ASAN</a>) fell 6.2% to $19.85.</li>
<li>The Gap, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gps#NYSE">GPS</a>) fell 5% to $11.00 as the company posted a wider-than-expected loss for its fourth quarter and issued weak full-year sales forecast.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/23/03/31296559/bitcoin-tumbles-below-this-key-level-conflux-huobi-token-among-top-losers"> Bitcoin Tumbles Below This Key Level; Conflux, Huobi Token Among Top Losers</a>

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AIRG

AIRS

AIXI

ALTG

ALTO

ASAN

BCAN

BIRD

BNED

BRDS

CMAX

CMTL

CNTY

DOCU

FRTX

GBNH

GCTK

GENI

HGBL

JAKK

JFBR

LUNR

LYLT

MMMB

MSGM

MTEM

MYPS

NVOS

NVVE

OCEA

ONCT

OPEN

PACW

PSTX

QTWO

RILY

RSKD

SBNY

SRRK

TGTX

TOVX

UNCY

VIEW

Why JAKKS Pacific Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Tuesday marks the last chance for investors to receive the next dividend payout from Mannatech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEX#NASDAQ">MTEX</a>). 
<h3>What's Happening</h3>
The company announced on Monday that it would pay shareholders a quarterly dividend of 20 cents per share. On Wednesday, Mannatech will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 20 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Wednesday. Shareholders who own MTEX as of the end of Tuesday's session are eligible to receive the 20 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on March 30, 2023. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
<a href="https://www.benzinga.com/stock//dividends">Click here</a> to find details on Mannatech's previous dividends.
To keep track of which companies are distributing dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

Dividends

Tuesday Is Your Last Chance To Buy Mannatech Before The Dividend Payout

<h3>What Defines a Value Stock?</h3>
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued. 
<h2>The following stocks are considered to be notable value stocks in the consumer defensive sector:</h2>
<ol>
<li>Herbalife Nutrition (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLF#NYSE">HLF</a>) - P/E: 5.97</li>
<li>Skillsoft (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKIL#NYSE">SKIL</a>) - P/E: 2.04</li>
<li>Sunlands Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STG#NYSE">STG</a>) - P/E: 1.62</li>
<li>Seneca Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SENEB#NASDAQ">SENEB</a>) - P/E: 8.89</li>
<li>Mannatech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEX#NASDAQ">MTEX</a>) - P/E: 7.42</li>
</ol>
Herbalife Nutrition saw a decrease in earnings per share from 0.91 in Q3 to $0.53 now. Most recently, the company reported a dividend yield of 1.71%, which has decreased by 1.82% from last quarter's yield of 3.53%.
Skillsoft saw a decrease in earnings per share from 0.09 in Q2 to $-0.19 now. Sunlands Technology saw an increase in earnings per share from 1.26 in Q2 to $1.69 now. Seneca Foods has reported Q3 earnings per share at $2.74, which has increased by 34.98% compared to Q2, which was 2.03. Mannatech has reported Q3 earnings per share at $0.61, which has increased by 79.41% compared to Q2, which was 0.34. The company's most recent dividend yield sits at 3.77%, which has increased by 0.57% from 3.2% last quarter. 
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.

SENEB

SKIL

Overview Of Value Stocks In The Consumer Defensive Sector

<h3>The Meaning Behind Value Stocks</h3>
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued. 
<h2>Below is a list of notable value stocks in the consumer defensive sector:</h2>
<ol>
<li>Ingles Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMKTA#NASDAQ">IMKTA</a>) - P/E: 7.03</li>
<li>Amcon Distributing (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/DIT#AMEX">DIT</a>) - P/E: 5.9</li>
<li>Industrias Bachoco SAB (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBA#NYSE">IBA</a>) - P/E: 7.3</li>
<li>Mannatech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEX#NASDAQ">MTEX</a>) - P/E: 9.78</li>
<li>Post Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/POST#NYSE">POST</a>) - P/E: 7.83</li>
</ol>
Ingles Markets has reported Q4 earnings per share at $3.69, which has increased by 3.36% compared to Q3, which was 3.57. The company's most recent dividend yield sits at 0.81%, which has increased by 0.05% from 0.76% last quarter. 
Amcon Distributing has reported Q4 earnings per share at $7.97, which has decreased by 22.4% compared to Q3, which was 10.27. Its most recent dividend yield is at 0.38%, which has increased by 0.01% from 0.37% in the previous quarter.
Industrias Bachoco SAB's earnings per share for Q3 sits at $0.97, whereas in Q2, they were at 2.94. Its most recent dividend yield is at 2.28%, which has increased by 0.23% from 2.05% in the previous quarter.
Mannatech has reported Q3 earnings per share at $0.61, which has increased by 79.41% compared to Q2, which was 0.34. The company's most recent dividend yield sits at 3.77%, which has increased by 0.57% from 3.2% last quarter. 
This quarter, Post Holdings experienced an increase in earnings per share, which was $0.69 in Q3 and is now $0.85. The company's most recent dividend yield sits at 6.43%, which has increased by 0.76% from 5.67% last quarter. 
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.

IMKTA

POST

A Look Into Consumer Defensive Sector Value Stocks

Mannatech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEX#NASDAQ">MTEX</a>) reported quarterly earnings of $0.61 per share. This is a 57.64 percent decrease over earnings of $1.44 per share from the same period last year. The company reported $35.50 million in sales this quarter. This is a 10.00 percent decrease over sales of $39.45 million the same period last year.

Mannatech Q3 EPS $0.61 Down From $1.44 YoY, Sales $35.50M Down From $39.45M YoY

<h3>What Defines a Value Stock?</h3>
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock. 
<h2>Below is a list of notable value stocks in the consumer defensive sector:</h2>
<ol>
<li>Mannatech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEX#NASDAQ">MTEX</a>) - P/E: 7.51</li>
<li>Bridgford Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRID#NASDAQ">BRID</a>) - P/E: 3.12</li>
<li>Bunge (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BG#NYSE">BG</a>) - P/E: 7.79</li>
<li>Andersons (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANDE#NASDAQ">ANDE</a>) - P/E: 8.91</li>
<li>Industrias Bachoco SAB (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBA#NYSE">IBA</a>) - P/E: 7.36</li>
</ol>
Mannatech has reported Q2 earnings per share at $0.34, which has increased by 466.67% compared to Q1, which was 0.06. The company's most recent dividend yield sits at 3.2%, which has decreased by 0.01% from 3.21% last quarter. 
Bridgford Foods's earnings per share for Q3 sits at $0.04, whereas in Q2, they were at -0.09. Bunge saw a decrease in earnings per share from 4.26 in Q1 to $2.97 now. The company's most recent dividend yield sits at 2.55%, which has increased by 0.27% from 2.28% last quarter. 
Andersons saw an increase in earnings per share from 0.18 in Q1 to $2.39 now. The company's most recent dividend yield sits at 1.85%, which has decreased by 0.12% from 1.97% last quarter. 
Industrias Bachoco SAB has reported Q2 earnings per share at $2.94, which has increased by 35.48% compared to Q1, which was 2.17. Its most recent dividend yield is at 2.28%, which has increased by 0.23% from 2.05% in the previous quarter.
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.

ANDE

BRID

5 Value Stocks To Watch In The Consumer Defensive Sector

Press Releases

Mannatech Announces Appointment of James Clavijo as Chief Financial Officer

Mannatech Reports Financial Results for Second Quarter 2024

Mannatech Reports Financial Results for Third Quarter 2024

Mannatech Announces Appointment of Robert A. Toth as Vice Chairman of the Board of Directors

Mannatech Reports Fourth Quarter 2024 Financial Results

Mannatech Reports Financial Results for First Quarter 2025

Mannatech Premieres Powerful New Documentary on Marathon Legend Steve Edwards

Mannatech Announces Results of Annual Shareholders' Meeting

AEZS

GTHP

LVGN

AXIL Brands

BellRing Brands

Coty

Big Tree Cloud Holdings Limited - Ordinary Shares

Big Tree Cloud Holdings

Estee Lauder Companies, Inc. (The) Common Stock

Estee Lauder Cos

e.l.f. Beauty

Edgewell Personal Care Company Common Stock

Edgewell Personal Care

FitLife Brands

Herbalife

Honest Co

Interparfums

Kenvue

Lifevantage

Medifast

Nature's Sunshine Products, Inc. - Common Stock

Natures Sunshine Products

Natural Health Trends Corp. - Commn Stock

Natural Health Trends

Nu Skin Enterprises

Olaplex Hldgs

Paranovus Entertainment Technology Ltd. - Class A Ordinary Shares

Paranovus Entertainment

The Beauty Health Company - Class A Common Stock

Beauty Health

United-Guardian

Unilever

Upexi

Usana Health Sciences

Waldencast

Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares

Yatsen Holding

Comments

Mannatech

뉴스

에 대한 최신 뉴스 Mannatech (NASDAQ:MTEX) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌